Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 21 November, 2024
Author: Getaka|Social: Getaka Financial Services X (Earlier Twitter) Profile Getaka Financial Services LinkedIn Logo

Metropolis Healthcare Ltd: Intrinsic Value and Fundamental Analysis

Share Price and Basic Stock Data

Last Updated: November 21, 2024, 9:47 pm

Market Cap 10,353 Cr.
Current Price 2,016
High / Low2,318/1,450
Stock P/E69.9
Book Value 231
Dividend Yield0.20 %
ROCE15.8 %
ROE12.2 %
Face Value 2.00
PEG Ratio100.15

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Metropolis Healthcare Ltd

Competitors of Metropolis Healthcare Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Global Longlife Hospital and Research Ltd 33.6 Cr. 32.061.7/27.0 25.90.00 %2.51 %4.72 % 10.0
Gian Lifecare Ltd 19.3 Cr. 18.629.0/17.04.73 19.20.00 %29.2 %24.6 % 10.0
Fortis Malar Hospitals Ltd 99.4 Cr. 53.0108/44.0 15.980.1 %3.29 %9.12 % 10.0
Family Care Hospitals Ltd 36.5 Cr. 6.7510.4/6.230.88 2.670.00 %15.4 %24.1 % 10.0
Dr Lalchandani Labs Ltd 8.12 Cr. 18.728.9/0.009.44 22.40.00 %2.68 %8.23 % 10.0
Industry Average28,352.25 Cr787.4249.9590.793.86%11.58%12.32%9.00

All Competitor Stocks of Metropolis Healthcare Ltd

Quarterly Result

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales275292327303293306280300285283277308291
Expenses188195224212218231211221215212214234226
Operating Profit879610290757568797070637565
OPM %32%33%31%30%26%24%24%26%25%25%23%24%22%
Other Income42206363471312
Interest2363568766665
Depreciation11141315171821222323212225
Profit before tax788210378565643554842394837
Tax %25%25%27%25%27%29%22%26%25%20%26%26%26%
Net Profit59617558414034403633293627
EPS in Rs11.4612.0014.6511.398.027.816.537.886.996.515.626.925.30

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales3884564755456477618569981,2281,1481,154
Expenses285339359405467559619708880855875
Operating Profit104117116140181203237290348293279
OPM %27%26%24%26%28%27%28%29%28%26%24%
Other Income107293968-1712341512
Interest3222441312253224
Depreciation1621171719203946638990
Profit before tax95101128160164187169244293188177
Tax %34%33%36%33%32%34%24%25%27%24%
Net Profit636882107112124128183215143134
EPS in Rs57.3461.8280.47106.52109.2323.9425.1535.8241.8527.9026.04
Dividend Payout %2%0%100%49%0%55%32%22%19%29%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-2023
YoY Net Profit Growth (%)7.94%20.59%30.49%4.67%10.71%3.23%42.97%17.49%-33.49%
Change in YoY Net Profit Growth (%)0.00%12.65%9.90%-25.81%6.04%-7.49%39.74%-25.48%-50.97%

Metropolis Healthcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2014-2015 to 2022-2023.

Growth

Compounded Sales Growth
10 Years:12%
5 Years:10%
3 Years:7%
TTM:11%
Compounded Profit Growth
10 Years:9%
5 Years:2%
3 Years:-11%
TTM:11%
Stock Price CAGR
10 Years:%
5 Years:7%
3 Years:-13%
1 Year:24%
Return on Equity
10 Years:22%
5 Years:21%
3 Years:17%
Last Year:12%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 8:32 pm

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital101010101010101010101010
Reserves2923522693144054085136968769781,0861,174
Borrowings20145111867112379266197189
Other Liabilities6987107188110113160181256240254258
Total Liabilities3914623915125265507501,0001,5211,4951,5471,631
Fixed Assets1491531422022072132963431,0591,1211,1771,173
CWIP1011063062000
Investments132168101142102331410161555132
Other Assets109141147167216298437647440340316327
Total Assets3914623915125265507501,0001,5211,4951,5471,631

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +77699110210490215249253247264
Cash from Investing Activity +-61-5696-86136-10463-73648-89
Cash from Financing Activity +-14-9-174-17-87-118-55-33163-292-181
Net Cash Flow2414-118856279-3213-6

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Free Cash Flow84.00103.00111.00139.00180.00185.00170.00178.00-31.0027.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days4757545457665545403938
Inventory Days4752463853554459686458
Days Payable759296978890152160136136150
Cash Conversion Cycle19173-52130-54-56-29-33-53
Working Capital Days22328-27284211414147
ROCE %28%34%46%43%43%40%36%29%17%16%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters50.33%49.50%49.79%49.79%49.76%49.76%49.75%49.75%49.75%49.74%49.67%49.62%
FIIs30.72%30.06%21.91%23.20%25.57%23.86%25.67%25.66%24.29%21.66%18.90%18.25%
DIIs12.26%11.35%16.20%14.50%12.38%13.30%13.64%14.89%16.86%20.73%24.86%27.42%
Public6.69%9.09%12.11%12.52%12.30%13.09%10.94%9.69%9.10%7.87%6.57%4.69%
No. of Shareholders43,55264,16879,89586,40490,09091,45284,26989,69286,24979,87868,28358,108

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Nippon India Small Cap Fund1,085,4110.45184.86550,0002024-11-2097.35%
UTI Flexi Cap Fund804,2300.54136.97550,0002024-11-2046.22%
Franklin India Smaller Companies Fund715,4591.13121.85550,0002024-11-2030.08%
UTI Large Cap Fund617,5180.9105.17550,0002024-11-2012.28%
UTI Value Fund550,0001.1793.67550,0002024-11-200%
Aditya Birla Sun Life Flexi Cap Fund506,0150.4886.18550,0002024-11-20-8%
UTI Mid Cap Fund418,8970.7671.34550,0002024-11-20-23.84%
Quant Small Cap Fund359,6680.5561.26550,0002024-11-20-34.61%
UTI ELSS Tax Saver Fund237,4421.2240.44550,0002024-11-20-56.83%
UTI Small Cap Fund218,8381.0837.27550,0002024-11-20-60.21%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue2.002.002.002.002.00
Basic EPS (Rs.)24.9527.9141.8735.9725.36
Diluted EPS (Rs.)24.8727.9141.6635.7925.25
Cash EPS (Rs.)43.5245.4254.3144.8633.05
Book Value[Excl.RevalReserv]/Share (Rs.)214.59193.46173.56138.52103.72
Book Value[Incl.RevalReserv]/Share (Rs.)214.59193.46173.56138.52103.72
Revenue From Operations / Share (Rs.)235.76224.21240.04195.24169.15
PBDIT / Share (Rs.)56.9459.2770.4358.3147.68
PBIT / Share (Rs.)38.5041.8558.0849.3239.92
PBT / Share (Rs.)34.1036.6157.3347.8033.43
Net Profit / Share (Rs.)25.0828.0041.9535.8725.30
NP After MI And SOA / Share (Rs.)24.9527.9041.8635.8225.15
PBDIT Margin (%)24.1526.4329.3429.8628.18
PBIT Margin (%)16.3318.6624.1925.2623.60
PBT Margin (%)14.4616.3323.8824.4819.76
Net Profit Margin (%)10.6312.4817.4718.3714.95
NP After MI And SOA Margin (%)10.5812.4417.4318.3414.86
Return on Networth / Equity (%)11.6614.4524.1125.9124.32
Return on Capital Employeed (%)15.0617.3224.1831.4934.68
Return On Assets (%)8.219.5113.9918.2216.92
Long Term Debt / Equity (X)0.000.020.170.000.00
Total Debt / Equity (X)0.000.070.290.000.00
Asset Turnover Ratio (%)0.790.750.950.961.07
Current Ratio (X)1.281.141.302.982.34
Quick Ratio (X)1.130.971.132.782.20
Dividend Payout Ratio (NP) (%)16.0328.6719.1122.3331.52
Dividend Payout Ratio (CP) (%)9.2117.6514.7517.8524.09
Earning Retention Ratio (%)83.9771.3380.8977.6768.48
Cash Earning Retention Ratio (%)90.7982.3585.2582.1575.91
Interest Coverage Ratio (X)12.9411.3218.2638.3028.93
Interest Coverage Ratio (Post Tax) (X)6.706.3511.0724.5619.29
Enterprise Value (Cr.)8775.736384.2710513.8111037.236303.53
EV / Net Operating Revenue (X)7.275.568.5611.067.36
EV / EBITDA (X)30.0921.0329.1737.0326.11
MarketCap / Net Operating Revenue (X)7.325.578.4811.487.60
Retention Ratios (%)83.9671.3280.8877.6668.47
Price / BV (X)8.076.4711.7316.2112.44
Price / Net Operating Revenue (X)7.325.578.4811.487.60
EarningsYield0.010.020.020.010.01

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Metropolis Healthcare Ltd as of November 21, 2024 is: 1,973.86

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of November 21, 2024, Metropolis Healthcare Ltd is Overvalued by 2.09% compared to the current share price 2,016.00

Intrinsic Value of Metropolis Healthcare Ltd as of November 21, 2024 is: 1,987.64

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of November 21, 2024, Metropolis Healthcare Ltd is Overvalued by 1.41% compared to the current share price 2,016.00

Last 5 Year EPS CAGR: 0.70%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 30.18%, which is a positive sign.
  2. The stock has a low average Working Capital Days of 14.09, which is a positive sign.
  3. The stock has a low average Cash Conversion Cycle of -12.73, which is a positive sign.
  4. The company has higher reserves (613.58 cr) compared to borrowings (105.75 cr), indicating strong financial stability.
  5. The company has shown consistent growth in sales (466.27 cr) and profit (173.27 cr) over the years.

    Stock Analysis

    • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Metropolis Healthcare Ltd:
      1. Net Profit Margin: 10.63%
        • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
      2. ROCE: 15.06% (Industry Average ROCE: 11.58%)
        • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
      3. ROE%: 11.66% (Industry Average ROE: 11.76%)
        • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
      4. Interest Coverage Ratio (Post Tax): 6.7
        • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
      5. Quick Ratio: 1.13
        • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
      6. Stock P/E: 69.9 (Industry average Stock P/E: 38.6)
        • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
      7. Total Debt / Equity: 0
        • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
      The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
      Stock Rating:

    About the Company - Qualitative Analysis

    Metropolis Healthcare Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L73100MH2000PLC192798 and registration number is 192798. Currently Company is involved in the business activities of Activities of independent diagnostic/pathological laboratories. Company’s Total Operating Revenue is Rs. 1117.13 Cr. and Equity Capital is Rs. 10.23 Cr. for the Year ended 31/03/2022.
    INDUSTRYADDRESSCONTACT
    Hospitals & Medical Services4th Floor, East Wing, Plot-254 B, Nirlon House, Mumbai Maharashtra 400030secretarial@metropolisindia.com
    http://www.metropolisindia.com
    Management
    NamePosition Held
    Dr. Sushil Kanubhai ShahChairman & Executive Director
    Mrs. Ameera Sushil ShahManaging Director
    Mr. Hemant SachdevNon Exe.Non Ind.Director
    Mr. Vivek GambhirIndependent Director
    Mr. Sanjay BhatnagarIndependent Director
    Ms. Anita RamachandranIndependent Director
    Mr. Subramanian RanganathanIndependent Director
    Dr. Aparna RajadhyakshaNon Exe.Non Ind.Director

    FAQ

    What is the latest intrinsic value of Metropolis Healthcare Ltd?

    The latest intrinsic value of Metropolis Healthcare Ltd as on 21 November 2024 is ₹1973.86, which is 2.09% lower than the current market price of ₹2,016.00.

    What is the Market Cap of Metropolis Healthcare Ltd?

    The Market Cap of Metropolis Healthcare Ltd is 10,353 Cr..

    What is the current Stock Price of Metropolis Healthcare Ltd as on 21 November 2024?

    The current stock price of Metropolis Healthcare Ltd as on 21 November 2024 is ₹2,016.

    What is the High / Low of Metropolis Healthcare Ltd stocks in FY 2024?

    In FY 2024, the High / Low of Metropolis Healthcare Ltd stocks is 2,318/1,450.

    What is the Stock P/E of Metropolis Healthcare Ltd?

    The Stock P/E of Metropolis Healthcare Ltd is 69.9.

    What is the Book Value of Metropolis Healthcare Ltd?

    The Book Value of Metropolis Healthcare Ltd is 231.

    What is the Dividend Yield of Metropolis Healthcare Ltd?

    The Dividend Yield of Metropolis Healthcare Ltd is 0.20 %.

    What is the ROCE of Metropolis Healthcare Ltd?

    The ROCE of Metropolis Healthcare Ltd is 15.8 %.

    What is the ROE of Metropolis Healthcare Ltd?

    The ROE of Metropolis Healthcare Ltd is 12.2 %.

    What is the Face Value of Metropolis Healthcare Ltd?

    The Face Value of Metropolis Healthcare Ltd is 2.00.

    About the Author

    Author Avatar
    Getaka

    Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

    Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Metropolis Healthcare Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE